Dr. Gradishar is on Doximity
As a Doximity member you'll join over two million verified healthcare professionals in a private, secure network.
- Gain access to free telehealth tools, such as our “call shielding” and one-way patient texting.
- Connect with colleagues in the same hospital or clinic.
- Read the latest clinical news, personalized to your specialty.
Office
675 N Saint Clair St
# Galter
Chicago, IL 60611Phone+1 312-695-0990Fax+1 312-695-1106
Education & Training
- University of ChicagoFellowship, Hematology and Medical Oncology, 1986 - 1989
- Michael Reese Hospital and Medical CenterResidency, Internal Medicine, 1982 - 1986
- University of Illinois College of MedicineClass of 1982
Certifications & Licensure
- IL State Medical License 1983 - 2026
- FL State Medical License 2013 - 2015
- American Board of Internal Medicine Internal Medicine
- American Board of Internal Medicine Medical Oncology
Awards, Honors, & Recognition
- America's Top Doctors Castle Connolly, 2009-2014
- Chicago Magazine: Top Doctors Castle Connolly, 2006, 2008, 2010, 2012, 2014
- America's Top Doctors for Cancer Castle Connolly, 2005-2013
- Join now to see all
Clinical Trials
- Chemotherapy in Treating Women With Previously Treated Metastatic Breast Cancer Start of enrollment: 1998 Jul 13
- Docetaxel, Doxorubicin, and Cyclophosphamide in Treating Women With Stage III Breast Cancer Start of enrollment: 1998 Nov 01
- Irinotecan in Treating Patients With Metastatic or Recurrent Breast Cancer Start of enrollment: 1999 Oct 01
- Join now to see all
Publications & Presentations
PubMed
- Integrating machine learning-predicted circulating tumor cells (CTCs) and circulating tumor DNA (ctDNA) in metastatic breast cancer: A proof of principle study on endo...Lorenzo Gerratana, Andrew A Davis, Lorenzo Foffano, Carolina Reduzzi, Tania Rossi
Cancer Letters. 2025-01-28 - 1 citationsFeasibility and preliminary effects of the Fit2ThriveMB pilot physical activity promotion intervention on physical activity and patient reported outcomes in individual...Siobhan M Phillips, Julia Starikovsky, Payton Solk, Ria Desai, Jean M Reading
Breast Cancer Research and Treatment. 2024-11-01 - Effective Strategies for the Prevention and Mitigation of Phosphatidylinositol-3-Kinase Inhibitor-Associated Hyperglycemia: Optimizing Patient Care.Heather N Moore, Marcus D Goncalves, Abigail M Johnston, Erica L Mayer, Hope S Rugo
Clinical Breast Cancer. 2024-09-28
Journal Articles
- Efficacy of Margetuximab vs Trastuzumab in Patients with Pretreated ERBB2-Positive Advanced Breast CancerDenise A Yardley, William J Gradishar, JAMA Oncology
- From the Past to the Present: Insurer Coverage Frameworks for Next-Generation Tumor SequencingWilliam J Gradishar, Al B Benson, Massimo Cristofanilli, Allison W Kurian, Value in Health
Lectures
- Predicting expected absolute chemotherapy treatment benefit in women with early-stage breast cancer using a 12-gene expression assay.2018 ASCO Annual Meeting - Chicago, Illinois - 06/2/2018
- Pros and Cons of Extended Adjuvant Endocrine Therapy2018 ASCO Annual Meeting - Chicago, Illinois - 06/1/2018
Other
- Breast cancer in menGradishar WJ
http://www.uptodate.com/contents/breast-cancer-in-men
UpToDate, Wolters Kluwer Health - 2013-02-20 - Axillary node metastases with occult primary breast cancerGradishar WJ, Kaklamani V
http://www.uptodate.com/contents/axillary-node-metastases-with-occult-primary-breast-cancer
UpToDate, Wolters Kluwer Health - 2012-08-07
Authored Content
- From the Past to the Present: Insurer Coverage Frameworks for Next-Generation Tumor SequencingAugust 2018
Press Mentions
- SABCS Session Explores Treatment Considerations in Metastatic ER+ Breast CancerDecember 6th, 2024
- Inavolisib Regimen Extends PFS in PIK3CA-Mutated Advanced Breast CancerOctober 31st, 2024
- INAVO120 Trial Tests Inavolisib in HR+, HER2-, PIK3C-Alpha-Mutated DiseaseOctober 30th, 2024
- Join now to see all
Professional Memberships
- Fellow
- Fellow
Viewing the full profile is available to verified healthcare professionals only.
Find your profile and take control of your online presence: